InnovAge (NASDAQ:INNV) Releases Quarterly Earnings Results

InnovAge (NASDAQ:INNVGet Free Report) posted its earnings results on Tuesday. The company reported ($0.10) EPS for the quarter, Zacks reports. InnovAge had a negative net margin of 2.03% and a negative return on equity of 5.68%. InnovAge updated its FY 2025 guidance to EPS.

InnovAge Stock Down 8.9 %

INNV stock opened at $3.36 on Thursday. InnovAge has a 12 month low of $3.12 and a 12 month high of $6.69. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.21 and a quick ratio of 1.21. The company has a market cap of $455.15 million, a price-to-earnings ratio of -28.00 and a beta of 0.37. The company has a fifty day moving average price of $4.04 and a 200 day moving average price of $5.23.

Analysts Set New Price Targets

A number of research firms have recently commented on INNV. JPMorgan Chase & Co. reiterated an “underweight” rating and issued a $5.00 price objective on shares of InnovAge in a report on Tuesday, December 17th. KeyCorp began coverage on shares of InnovAge in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock.

View Our Latest Analysis on INNV

About InnovAge

(Get Free Report)

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.

Read More

Earnings History for InnovAge (NASDAQ:INNV)

Receive News & Ratings for InnovAge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InnovAge and related companies with MarketBeat.com's FREE daily email newsletter.